Clinical Trial Update: An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American Participants

View source ↗

Summary

An observational study evaluating HER2 status in breast invasive carcinoma among Latin American participants; the study completed and posted results in April 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2017-04-10